Arvio M, Oksanen V, Autio S, Gaily E, Sainio K
Pääjärvi Rehabilitation Centre, Lammi, Finland.
Acta Neurol Scand. 1993 May;87(5):342-4. doi: 10.1111/j.1600-0404.1993.tb04114.x.
Aspartylglucosaminuria (AGU) is a lysosomal storage disorder with reduced life-span. An analysis of 121 Finnish patients showed that 22 to 78 adults (28%) and one of 43 children (2%) had epileptic seizures. Twelve patients had the onset of attacks after the age of 30 years. Eleven patients had generalized, nine partial and three unclassified seizures. The response to carbamazepine was good. The major interictal EEG abnormality was the attenuation of the amplitude found in 10/27 patients. The brain CT-scans showed diffuse atrophy in 8/11 patients.
天冬氨酰葡萄糖胺尿症(AGU)是一种会缩短寿命的溶酶体贮积症。对121名芬兰患者的分析显示,22至78名成年人(28%)以及43名儿童中的1名(2%)有癫痫发作。12名患者在30岁之后开始发作。11名患者为全身性发作,9名患者为部分性发作,3名患者发作类型未分类。对卡马西平的反应良好。发作间期脑电图的主要异常表现为10/27的患者出现波幅衰减。11名患者中的8名脑部CT扫描显示有弥漫性萎缩。